NASDAQ:TTRX Turn Therapeutics Q3 2026 Earnings Results & Report $9.82 +0.03 (+0.32%) As of 02:18 PM Eastern This is a fair market value price provided by Massive. Learn more. Turn Therapeutics reported Q3 2026 earnings on November 9, 2026. The company reported EPS of -$0.21. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 9, 2026TimeBefore Market OpensConference Call7:00 AM ET Turn Therapeutics EPS ResultsActual EPS-$0.21Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ATurn Therapeutics Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Turn Therapeutics Q3 2026 Earnings FAQ Did Turn Therapeutics beat earnings estimates for Q3 2026? Turn Therapeutics (NASDAQ:TTRX) reported earnings of -$0.21 per share for Q3 2026. The report was announced on Monday, November 9, 2026. Turn Therapeutics Earnings HeadlinesTurn Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 9 at 4:29 PM | marketscreener.comMTurn Therapeutics Inc. GAAP EPS of -$0.21November 9 at 7:51 AM | seekingalpha.comA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.November 10 at 1:00 AM | Behind the Markets (Ad)Turn Therapeutics (NASDAQ:TTRX) Stock Rating Lowered by Wall Street ZenNovember 8 at 1:13 AM | americanbankingnews.comTurn Therapeutics’ GX-03 Earns "Developmental Immunology Solution of the Year" in 2026 BioTech Breakthrough Awards ProgramNovember 5, 2026 | finance.yahoo.comTurn Therapeutics (NASDAQ:TTRX) Stock Rating Raised to "Hold" at Wall Street ZenOctober 31, 2026 | americanbankingnews.comSee More Turn Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Turn Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Turn Therapeutics and other key companies, straight to your email. Email Address About Turn TherapeuticsTurn Therapeutics (NASDAQ:TTRX), Inc. is a biotechnology and pharmaceutical company focused on developing topical therapies for skin and wound-care applications. The company’s platform is designed to support the delivery of therapeutic compounds to the skin while helping address microbial contamination and other complications associated with wounds. Turn Therapeutics has identified MVT-100 as a lead product candidate. The topical formulation is intended for use in wound-care settings, including the management of chronic and difficult-to-heal wounds. The company has also described potential applications for its technology in other dermatological conditions. Publicly available information about Turn Therapeutics’ operating history, geographic reach and current leadership is limited. Its activities have primarily centered on advancing its topical product candidates and pursuing the regulatory and clinical development work required to support commercialization.View Turn Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles DraftKings Just Lost 20%—And Its Biggest Gamble Is Still AheadBarrick's Earnings Beat Could Be Overshadowed by an Even Bigger OpportunityAxon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?Wall Street May Be Making a Big Mistake With monday.com StockCloudflare's 20% Sell-Off May Have Created an Opening for InvestorsMarketBeat Week in Review – 11/2 - 11/6 Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
